Novartis Foundation Symposium 292: Defining Optimal Immunotherapies for Type 1 Diabetes

Título:
Novartis Foundation Symposium 292: Defining Optimal Immunotherapies for Type 1 Diabetes
Materia:
Internal Medicine; Endocrinology & Metabolism
Editor:
John Wiley & Sons, Inc.
Identificadores:
E-ISBN: 9780470723258
Colección:
OVID